Contrasting Joint (JYNT) & iKang Healthcare Group (KANG)

Joint (NASDAQ: JYNT) and iKang Healthcare Group (NASDAQ:KANG) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, dividends and analyst recommendations.

Analyst Recommendations

This is a summary of current recommendations for Joint and iKang Healthcare Group, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Joint 0 0 4 0 3.00
iKang Healthcare Group 0 0 0 0 N/A

Joint presently has a consensus price target of $6.15, indicating a potential upside of 22.51%. Given Joint’s higher possible upside, research analysts plainly believe Joint is more favorable than iKang Healthcare Group.

Insider and Institutional Ownership

46.7% of Joint shares are owned by institutional investors. Comparatively, 34.3% of iKang Healthcare Group shares are owned by institutional investors. 6.1% of Joint shares are owned by company insiders. Comparatively, 30.2% of iKang Healthcare Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Joint and iKang Healthcare Group’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Joint $20.52 million 3.31 -$15.17 million ($0.69) -7.28
iKang Healthcare Group $435.71 million 2.60 -$11.25 million $0.04 407.50

iKang Healthcare Group has higher revenue and earnings than Joint. Joint is trading at a lower price-to-earnings ratio than iKang Healthcare Group, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Joint and iKang Healthcare Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Joint -36.74% -98.28% -32.61%
iKang Healthcare Group 0.79% 1.30% 0.60%

Volatility & Risk

Joint has a beta of 1.44, indicating that its share price is 44% more volatile than the S&P 500. Comparatively, iKang Healthcare Group has a beta of 0.3, indicating that its share price is 70% less volatile than the S&P 500.

Summary

iKang Healthcare Group beats Joint on 7 of the 12 factors compared between the two stocks.

About Joint

The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. The Company has approximately 310 franchised, company-owned, or managed clinics in operation in over 30 states. In addition to its approximately 310 operating clinics, the Company has granted franchises either directly or through its regional developers for an additional over 170 clinics. The Company offers a range of membership and wellness packages. Each patient’s records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.

About iKang Healthcare Group

iKang Healthcare Group, Inc. provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Company’s segments include medical examinations and other medical services, and dental services. The Company, through its integrated service platform, offers healthcare management solutions, including medical examinations, which cover basic examination items, such as internal, gynecology, ophthalmology, dental and X-ray, and value-added services at selected medical centers, including disease screening focusing on cancer screening, cardiovascular disease screening, certain chronic disease screening and functional medicine testing; dental care, including oral health, pediatric dentistry and cosmetic dentistry; outpatient services, such as acupuncture, obstetrics, gynecology and minor surgery, and on-site healthcare management or clinics at certain locations.

Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply